fosun pharma usa, inc

Post on 06-Apr-2022

7 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Fosun Pharma USA, Inc.

Proposal• US FDA EUA APPROVED

• RT-PCR Detects Active infection with nCov-19 with 99.5% Sensitivity and 96.4% Specificity

• Robust supply chain; Manufacturer and Supplier both large public companies with US based operations

• US Based Customer Support for the product

• Supply Capacity for United States of 1 MILLION tests per week

• Total time from purchase order to receipt of product is typically 2-4 weeks and will depend on quantity

• >$100 CMS & private insurance reimbursement for High Capacity PCR testing

US

FDA

EUA

• Level of Laboratory: High Complexity

• Intended User: Expert Laboratory Personnel experienced in PCR

For more information contact:

Dr. Farhoud Khosravi Chief Operating Officer FK@testingimmunity.com

Thank you!

top related